Author

Pin-wen Wang

Observed names: Pin-Wen Wang, Wang, Pin-wen

Observed institution: Genentech

OpenAlex ID: A5041378794

Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion

2019 · Glenn Yiu, R. Joel Welch, et al. · Ophthalmology Retina · 75

Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema

2015 · Alok S. Bansal, Rahul N. Khurana, et al. · Ophthalmology · 64

PDF

Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE

2016 · Dante J. Pieramici, Pin-wen Wang, et al. · Ophthalmology · 57

PDF

Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials

2019 · Victor H. Gonzalez, Pin-wen Wang, et al. · Ophthalmology · 31

Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab

2018 · Jennifer K. Sun, Pin-wen Wang, et al. · Ophthalmology · 26

Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with Ranibizumab

2019 · Raafay Sophie, Pin-wen Wang, et al. · Ophthalmology · 16

Custody Plans Among Parents Living With Human Immunodeficiency Virus Infection

2004 · Mary Jane Rotheram-Borus, Patricia Lester, et al. · Archives of Pediatrics and Adolescent Medicine · 16

Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusion

2019 · W. Lloyd Clark, Mimi Liu, et al. · BMC Ophthalmology · 14

PDF

Long-Term Vision Outcomes in Patients With DME and a Limited Early Visual Response to Ranibizumab in RIDE and RISE

2020 · Rishi P. Singh, Dante J. Pieramici, et al. · Ophthalmic surgery, lasers & imaging retina · 9

Disease-modifying effects of ranibizumab for central retinal vein occlusion

2021 · Jason M. Huang, Rahul N. Khurana, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 5

PDF

Baseline predictors of early visual acuity improvement in RVO patients treated with ranibizumab in the SHORE study

2015 · Mimi Liu, Pin-wen Wang, et al. · Investigative Ophthalmology & Visual Science · 4

Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin

2016 · Pin-Wen Wang, Shou-En Lu, et al. · Journal of Statistical Planning and Inference · 2

Branch and central retinal vein occlusion: clinical pearls from trials of ranibizumab

2017 · Mimi Liu, David Eichenbaum, et al. · Investigative Ophthalmology & Visual Science · 1

Two-stage winner designs for non-inferiority trials with two to three experimental treatments and an active control

2013 · Wang, Pin-wen · Rutgers University Community Repository (Rutgers University) · 1

RVO cross trial comparison: six-month outcomes in anti-VEGF-treated patients with branch and central retinal vein occlusion

2017 · Nikolas London, Pin-wen Wang, et al. · Investigative Ophthalmology & Visual Science

Prevalence of drusen and conversion to neovascular age-related macular degeneration in the HARBOR study fellow eyes

2016 · Caroline R. Baumal, Carlos Quezada Ruíz, et al. · Investigative Ophthalmology & Visual Science

Individualized ranibizumab dosing effective for maintaining visual acuity gains in patients with BRVO and CRVO

2016 · Mimi Liu, Pin-wen Wang, et al. · Investigative Ophthalmology & Visual Science

Pan-retinal photocoagulation for diabetic retinopathy: is it one and done?

2016 · Víctor H. González, Pin-wen Wang, et al. · Investigative Ophthalmology & Visual Science

Durability of diabetic retinopathy improvement and impact of delayed therapy with ranibizumab (RBZ) during the RIDE/RISE open-label extension (OLE)

2015 · Jennifer K. Sun, Pin-wen Wang, et al. · Investigative Ophthalmology & Visual Science

Works count: 19

Citation count: 321

H-index: 9

I10-index: 8